THEOPHYLLINE-SR Drug Patent Profile
✉ Email this page to a colleague
When do Theophylline-sr patents expire, and when can generic versions of Theophylline-sr launch?
Theophylline-sr is a drug marketed by Scherer Rp and is included in one NDA.
The generic ingredient in THEOPHYLLINE-SR is theophylline. There are thirty-six drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the theophylline profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Theophylline-sr
A generic version of THEOPHYLLINE-SR was approved as theophylline by RHODES PHARMS on September 1st, 1982.
Summary for THEOPHYLLINE-SR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 171 |
Clinical Trials: | 109 |
Patent Applications: | 6,307 |
Formulation / Manufacturing: | see details |
DailyMed Link: | THEOPHYLLINE-SR at DailyMed |
Recent Clinical Trials for THEOPHYLLINE-SR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Oklahoma | Phase 1/Phase 2 |
Medical College of Wisconsin | Phase 1/Phase 2 |
University of California, Los Angeles | Early Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for THEOPHYLLINE-SR
US Patents and Regulatory Information for THEOPHYLLINE-SR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scherer Rp | THEOPHYLLINE-SR | theophylline | CAPSULE, EXTENDED RELEASE;ORAL | 088255-001 | Jun 12, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |